An increasing manual regression suite means more than just an additional workload. In regulated environments, it also poses an increasing compliance risk over time. Such environments include the life sciences, medical technology, pharmaceuticals, banking, insurance, aviation and the public sector — areas in which software systems and quality assurance (QA) are subject to strict validation, traceability, documentation and auditability requirements.
Most QA teams reach this point sooner or later. In regulated environments, however, the implications are particularly significant. What begins as a manageable number of tests can grow into hundreds of regression test cases over time. With each new release, many of these must be rerun because the approach of assuming that 'it'll probably work' is not acceptable in regulated environments.
At first, this development seems like purely a capacity issue. Over time, however, it becomes clear that there is more to it than that. Manual regression tests rarely fail at a single, clearly identifiable moment. Rather, quality assurance gradually loses its reliability: testing activities are conducted under time pressure, evidence is documented less consistently, and small differences between individual test cycles go unnoticed — until the worst possible moment when the question arises that cannot be answered with certainty.
The challenge lies not only in the fact that regression tests are time-consuming. More critically, repeated manual execution increases the likelihood of inconsistencies. In regulated industries, such deviations compromise efficiency, traceability, reproducibility and confidence in the evidence underlying release decisions.
This is precisely why automating regression tests is crucial. Not only does it increase throughput, it also reduces variability in the execution and documentation of tests.
In regulated environments, test automation only creates real added value if the tool itself is also under control. This is precisely where many teams underestimate the real challenge. They develop a robust test suite, but treat it more as an internal engineering tool than as a controlled component of a validated testing environment.
This approach works until the need arises to demonstrate what was executed, when, against which build and under what conditions. At that point, simple pass/fail results are no longer sufficient.
A test environment that can withstand scrutiny requires several foundational elements:
Test scripts must be versioned, stored, and reviewed just like any other controlled artifact.
Execution results must be available in a structured format and linked to a defined build, environment, and requirement.
Test environments must be clearly separated—including a documented rationale for what is being tested where.
None of these foundational elements typically ranks at the top of the priority list in day-to-day project work. Especially during intensive implementation phases or immediately before a release, they are easily overlooked due to time constraints and consequently put on the back burner. In practice, however, it becomes clear that the effort does not disappear — it simply shifts. This often only becomes apparent and costly during audit preparation, when the scope for action is significantly more limited.
The number of scripts does not determine whether a regression suite is audit-ready; it is the reliability of its results that matters. It is crucial that tests are executed reliably and generate traceable, structured, verifiable evidence, even for auditors and reviewers outside the immediate delivery team.
Simply logging test runs technically is not enough. What is required is a consistent and verifiable link between the test objective, execution, and result. This is precisely what an automation strategy in regulated environments should be guided by, especially in industries such as life sciences, medical technology, and pharmaceuticals. Execution speed is not the only decisive factor; the quality and traceability of the results produced are also important.
Once the technical foundations of test automation are in place, it is prioritisation that determines its actual value. Many teams start with test cases that are particularly easy to automate. While this may seem efficient at first, it does not necessarily result in a test suite that effectively covers all relevant risks.
It makes more strategic sense to base prioritization on the potential damage: Which errors would have the greatest operational or regulatory impact? Test cases involving incorrect calculations, corrupted audit trails or initially undetected data integrity issues should therefore take priority over less critical paths, even if the latter would be easier to automate.
The decision regarding which test cases to automate first should be documented in a transparent manner. This is not just a formality; the underlying rationale matters. If questions arise later as to why one area was prioritised over another, simply stating that it was 'next in line' will not suffice.
This is precisely what risk-based prioritisation provides. It creates a sound basis for decision-making, making it clear that regression tests were deliberately structured according to product risk, compliance relevance and operational impact.
Therefore, automating regression tests in regulated environments does not mean replacing manual work with scripts as quickly as possible. The crucial thing is to establish a controlled, verifiable and scalable approach to the tests that truly matter from technical, operational and regulatory perspectives.
Those who understand and prioritise the automation of regression tests in this way will not only achieve greater efficiency in quality assurance, but also strengthen traceability, the quality of evidence and auditability. This is where its true value lies, especially in industries where quality and compliance are inextricably linked.
Building Automation Strategically and in an Audit-Ready Manner
Would you like to set up your regression tests in a regulated environment that is audit-ready, efficient and future-proof? Talk to us about integrating test automation, traceability and compliance requirements into your QA process.